Lindor, Keith D.

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E., & Koch, A. (2011) · Gastroenterology

Liver Diseases and ImmunityBone health and osteoporosis research

Cited by 133

Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis

Lazaridis, K. N., Juran, B. D., Boe, G. M., Slusser, J. P., de Andrade, M., Homburger, H. A., Ghosh, K., Dickson, R. E., Lindor, K. D., & Petersen, G. M. (2007) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 128

Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system

Talwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 127

Novel therapeutic targets in primary biliary cirrhosis

Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. D., & Jones, D. E. J. (2015) · Nature Reviews Gastroenterology & Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 120

Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis

Talwalkar, J. A., Angulo, P., Johnson, D. C., Petersen, B. T., & Lindor, K. D. (2004) · Hepatology

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 119

Fat-soluble vitamin levels in patients with primary biliary cirrhosis

Phillips, J. R., Angulo, P., Petterson, T., & Lindor, K. D. (2001) · The American Journal of Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 118

Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis

Neuhauser, M., Bjornsson, E., Treeprasertsuk, S., Enders, F., Silveira, M., Talwalkar, J., & Lindor, K. (2010) · American Journal of Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 116

Ursodeoxycholic Acid for the Treatment of Primary Biliary Cirrhosis

Lindor, K. (2007) · New England Journal of Medicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 115

Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis

Zein, C. O., Lindor, K. D., & Angulo, P. (2004) · Hepatology

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 109

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Murillo Perez, C. F., Fisher, H., Hiu, S., Kareithi, D., Adekunle, F., Mayne, T., Malecha, E., Ness, E., van der Meer, A. J., Lammers, W. J., et al. (2022) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 107

Incidence of cancer in primary biliary cirrhosis: the Mayo experience

Nijhawan, P. K., Therneau, T. M., Dickson, R. E., Boynton, J., & Lindor, K. D. (1999) · Hepatology

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 99

When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

Zein, C. O., Angulo, P., & Lindor, K. D. (2003) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 99

Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., et al. (2015) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 97

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

Tabibian, J. H., Talwalkar, J. A., & Lindor, K. D. (2013) · BioMed Research International

Liver Diseases and ImmunityGut microbiota and health

Cited by 91

Milder disease stage in patients with primary biliary cholangitis over a 44‐year period: A changing natural history

Murillo Perez, C. F., Goet, J. C., Lammers, W. J., Gulamhusein, A., van Buuren, H. R., Ponsioen, C. Y., Carbone, M., Mason, A., Corpechot, C., Invernizzi, P., et al. (2018) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 88

American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis

Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. D., & Mayo, M. J. (2010) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 87

Recurrent primary biliary cirrhosis after liver transplantation

Silveira, M. G., Talwalkar, J. A., Lindor, K. D., & Wiesner, R. H. (2010) · American Journal of Transplantation

Liver Diseases and ImmunityOrgan Transplantation Techniques and Outcomes

Cited by 86

Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?

Yang, W.-H., Yu, J. H., Nakajima, A., Neuberg, D., Lindor, K., & Bloch, D. B. (2004) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 83

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E., & Lindor, K. D. (2012) · Liver International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 77

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Jorgensen, R. A., Dickson, E. R., Hofmann, A. F., Rossi, S. S., & Lindor, K. D. (1995) · Gut

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 77

Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis

Silveira, M. G., Suzuki, A., & Lindor, K. D. (2008) · Hepatology

Liver Diseases and ImmunityHepatocellular Carcinoma Treatment and Prognosis

Cited by 68

Unmet clinical need in autoimmune liver diseases

Dyson, J. K., Webb, G., Hirschfield, G. M., Lohse, A., Beuers, U., Lindor, K., & Jones, D. E. J. (2015) · Journal of Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 66

A randomized, placebo‐controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H., & Lindor, K. D. (2017) · American Journal of Therapeutics

Liver Diseases and ImmunityFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 64

Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis

Osman, K. T., Maselli, D. B., Idilman, I. S., Rowan, D. J., Viehman, J. K., Harmsen, W. S., Harnois, D. M., Carey, E. J., Gossard, A. A., LaRusso, N. F., et al. (2021) · Journal of Clinical Gastroenterology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 64